Stem cell therapy is emerging as a potential treatment for different conditions in endocrinology, including diabetes and ...
Svendsen's research has focused on neurodegenerative ... Scott Thies, Ph.D. Senior Director, Stem Cell Biology, Fate Therapeutics, San Diego, California, USA. Fate Therapeutics, founded in 2007 ...
Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and ...
Tenaya Therapeutics (TNYA) announced that the California Institute for Regenerative Medicine, CIRM,, a state of California Agency that funds ...
Cynata Therapeutics (ASX:CYP) has had its induced pluripotent stem cell (iPSC) derived mesenchymal stem cell (MSCs) verified as similar to convention MSCs in a study published in a peer-review journal ...